Bliss GVS Pharma reports consolidated net profit of Rs 27.94 crore in the December 2022 quarter

Capital Market Capital Market Automatic

Last Updated : Jan 25 2023 | 9:05 AM IST

Sales decline 4.87% to Rs 205.72 croreNet profit of Bliss GVS Pharma reported to Rs 27.94 crore in the quarter ended December 2022 as against net loss of Rs 50.11 crore during the previous quarter ended December 2021. Sales declined 4.87% to Rs 205.72 crore in the quarter ended December 2022 as against Rs 216.26 crore during the previous quarter ended December 2021. ParticularsQuarter EndedDec. 2022Dec. 2021% Var.Sales205.72216.26 -5 OPM %23.1815.80 -PBDT52.0739.16 33 PBT47.4334.73 37 NP27.94-50.11 LP

Powered by Capital Market - Live News

First Published: Jan 25 2023 | 9:05 AM IST

[{"banner_id":"1038","user_type":"Free","content_type":"banner_html","con_banner_code":"rnrn

rn rn

","device_type":"desktop"}]

In this section
All

read
shared
commented

Bliss GVS Pharma reports consolidated net profit of Rs 27.94 crore in the December 2022 quarter

In this section

All

Rs 127-bn scam: PNB MD Sunil Mehta appears before SFIO to record statement

30 of 47 firms that raised funds via QIP are trading below issue prices

India pitching for sovereign rating upgrade to Fitch: FinMin official

Citibank launches home loan product linked to an external benchmark

Latest_News__Native_InThisSection

read

shared

commented

Why does this ex-deputy guv of RBI want India's biggest firms dismantled?

Sebi to put in place framework to prevent frauds by stock brokers

Adani group pulls back on grand ambitions after the Hindenburg bombshell

Centre to borrow 57.55% of its full-year target in H1FY24: FinMin

MostPopular_Native_Ad_Read

Bliss GVS Pharma reports consolidated net profit of Rs 27.94 crore in the December 2022 quarter

Also Read

Bliss GVS Pharma consolidated net profit rises 6.06% in the June 2022 quarter

Bliss GVS Pharma consolidated net profit declines 34.88% in the September 2022 quarter

Aurobindo Pharma arm gets USFDA nod for fungal infection drug

Benchmarks near the day's high; pharma stocks witnessed bargain buying

Aurobindo Pharma's step-down subsidiary to commercialize Ryzneuta in the United States

Allsec Technologies consolidated net profit declines 45.14% in the December 2022 quarter

Nazara Technologies consolidated net profit rises 75.73% in the December 2022 quarter

Cartrade Tech reports consolidated net profit of Rs 13.03 crore in the December 2022 quarter

Agro Tech Foods consolidated net profit rises 1.34% in the December 2022 quarter

Paramount Communications consolidated net profit rises 422.63% in the December 2022 quarter

In this section

All

read

shared

commented